secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2021-07-02T23:59:59+00:00
Accession:  0001493152-21-016077
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics enters ATM equity offering agreement for up to $10M
---------------------------------------------------------------------------

- Entered into ATM Sales Agreement with B. Riley Securities and EF Hutton to sell up to $10M of common stock.
- Commission of 3.0% of gross sales price; agents use commercially reasonable efforts to sell shares.
- Offering made under S-3 shelf registration (No. 333-256790) effective June 23, 2021.
- Company not obligated to sell shares; agreement can be terminated by either party upon notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315221016077/0001493152-21-016077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315221016077/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-016077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer